plat

(redirected from tissue-type plasminogen activator)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

plat

A plan or survey map of a parcel of land.Developers file subdivision plats showing block and lot numbers, the dimensions and locations of individual lots, and the dimensions and locations of dedicated streets. Legal descriptions for properties within the subdivision are then made by reference to the recorded plat,such as “Lot 2,Block 3 of Harper Downs II as recorded in Plat Book 213,Page 82, of the Judge of Probate of Jefferson County,Alabama.”

References in periodicals archive ?
Pannekoek, "Kinetic characterization of tissue-type plasminogen activator (t-PA) and t-PA deletion mutants," Thrombosis and Haemostasis, vol.
Hart, "In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions," Cardiovascular Research, vol.
Soluble expression and purification of human tissue-type plasminogen activator protease domain.
Those who presented within 3 hours of symptom onset had to be ineligible for, or refractory to recombinant tissue-type plasminogen activator (rTPA) therapy to be enrolled.
He agreed that recombinant tissue-type plasminogen activator (rt-PA), urokinase, and streptokinase are not believed to cross to an embryo or fetus in amounts sufficient to cause hemorrhage.
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset.
Specifically, the researchers have examined the effects of alcohol and polyphenols on the expression of proteins and pathways that can lead to increased fibrinolysis (including, tissue-type plasminogen activator, t-PA; urokinase-type plasminogen activator, u-PA and plasminogen activator inhibitor type 1, PAI-1).
When a person is rushed to an emergency room with a heart attack or stroke, doctors often prescribe immediate infusions of tissue-type plasminogen activator (tPA).
Australian researchers, seeking to compare DSPA with tissue-type plasminogen activator, injected 16 mice with a neurotoxin and with either DSPA or tissue-type plasminogen activator (Stroke 34[2]:537-43, 2003).
Collen, "Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a noninhibitory substrate for tissue-type plasminogen activator," Journal of Biological Chemistry, vol.